2-chloro-4-[[4-[1-(5-cyclopropylpyrimidin-2-yl)ethylamino]-1-methyl-2-oxoquinolin-6-yl]amino]pyridine-3-carbonitrile
C25H22ClN7O — CID 142478328
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-chloro-4-[[4-[1-(5-cyclopropylpyrimidin-2-yl)ethylamino]-1-methyl-2-oxoquinolin-6-yl]amino]pyridine-3-carbonitrile
2-chloro-4-[[4-[1-(5-cyclopropylpyrimidin-2-yl)ethylamino]-1-methyl-2-oxoquinolin-6-yl]amino]pyridine-3-carbonitrile (PubChem CID 142478328) has the molecular formula C25H22ClN7O and a molecular weight of 471.95 g/mol. Its IUPAC name is 2-chloro-4-[[4-[1-(5-cyclopropylpyrimidin-2-yl)ethylamino]-1-methyl-2-oxoquinolin-6-yl]amino]pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | 2-chloro-4-[[4-[1-(5-cyclopropylpyrimidin-2-yl)ethylamino]-1-methyl-2-oxoquinolin-6-yl]amino]pyridine-3-carbonitrile |
|---|---|
| PubChem CID | 142478328 |
| Molecular Formula | C25H22ClN7O |
| Molecular Weight | 471.95 g/mol |
| Exact Mass | 471.16 |
| IUPAC Name | 2-chloro-4-[[4-[1-(5-cyclopropylpyrimidin-2-yl)ethylamino]-1-methyl-2-oxoquinolin-6-yl]amino]pyridine-3-carbonitrile |
| SMILES | CC(Nc1cc(=O)n(C)c2ccc(Nc3ccnc(Cl)c3C#N)cc12)c1ncc(C2CC2)cn1 |
| InChI | InChI=1S/C25H22ClN7O/c1-14(25-29-12-16(13-30-25)15-3-4-15)31-21-10-23(34)33(2)22-6-5-17(9-18(21)22)32-20-7-8-28-24(26)19(20)11-27/h5-10,12-15,31H,3-4H2,1-2H3,(H,28,32) |
| InChIKey | FHLDBZWADXDVDT-UHFFFAOYSA-N |
| XLogP | 5.04 |
| TPSA | 108.52 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 471.95 |
| LogP ≤ 5 | 5.04 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142478328 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.